Free Trial

MEDIROM Healthcare Technologies (MRM) Competitors

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)
Free MRM Stock Alerts
$5.41
+0.23 (+4.44%)
(As of 05/8/2024 ET)
Compare
Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media

MRM vs. XWEL, NTRB, FBRX, APRE, ACST, FEMY, BIAF, UBX, BCLI, and EVGN

Should you be buying MEDIROM Healthcare Technologies stock or one of its competitors? The main competitors of MEDIROM Healthcare Technologies include XWELL (XWEL), Nutriband (NTRB), Forte Biosciences (FBRX), Aprea Therapeutics (APRE), Acasti Pharma (ACST), Femasys (FEMY), bioAffinity Technologies (BIAF), Unity Biotechnology (UBX), Brainstorm Cell Therapeutics (BCLI), and Evogene (EVGN). These companies are all part of the "medical" sector.

MEDIROM Healthcare Technologies vs.

MEDIROM Healthcare Technologies (NYSE:MRM) and XWELL (NASDAQ:XWEL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, community ranking, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.

8.7% of XWELL shares are owned by institutional investors. 40.2% of MEDIROM Healthcare Technologies shares are owned by insiders. Comparatively, 4.9% of XWELL shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

XWELL has a consensus target price of $7.00, indicating a potential upside of 266.49%. Given XWELL's higher probable upside, analysts plainly believe XWELL is more favorable than MEDIROM Healthcare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MEDIROM Healthcare Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
XWELL
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

XWELL received 3 more outperform votes than MEDIROM Healthcare Technologies when rated by MarketBeat users.

CompanyUnderperformOutperform
MEDIROM Healthcare TechnologiesN/AN/A
XWELLOutperform Votes
3
75.00%
Underperform Votes
1
25.00%

MEDIROM Healthcare Technologies has a beta of 0.06, indicating that its stock price is 94% less volatile than the S&P 500. Comparatively, XWELL has a beta of 2.39, indicating that its stock price is 139% more volatile than the S&P 500.

MEDIROM Healthcare Technologies has higher revenue and earnings than XWELL.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MEDIROM Healthcare Technologies$53.25M0.50$1.15MN/AN/A
XWELL$30.11M0.27-$27.74M-$6.75-0.28

In the previous week, XWELL had 1 more articles in the media than MEDIROM Healthcare Technologies. MarketBeat recorded 2 mentions for XWELL and 1 mentions for MEDIROM Healthcare Technologies. MEDIROM Healthcare Technologies' average media sentiment score of 0.00 equaled XWELL'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MEDIROM Healthcare Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
XWELL
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

MEDIROM Healthcare Technologies has a net margin of 0.00% compared to XWELL's net margin of -92.14%. MEDIROM Healthcare Technologies' return on equity of 0.00% beat XWELL's return on equity.

Company Net Margins Return on Equity Return on Assets
MEDIROM Healthcare TechnologiesN/A N/A N/A
XWELL -92.14%-65.58%-41.35%

Summary

MEDIROM Healthcare Technologies beats XWELL on 7 of the 13 factors compared between the two stocks.

Get MEDIROM Healthcare Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRM vs. The Competition

Export to Excel
MetricMEDIROM Healthcare TechnologiesPersonal services IndustryMedical SectorNYSE Exchange
Market Cap$26.40M$1.15B$5.01B$17.72B
Dividend YieldN/A2.26%2.87%3.52%
P/E RatioN/A256.47174.6824.80
Price / Sales0.5034.242,407.6610.75
Price / Cash10.0430.2734.0315.59
Price / Book-60.1118.294.955.10
Net Income$1.15M$45.86M$105.41M$967.52M
7 Day Performance-1.28%0.73%0.38%1.66%
1 Month Performance-10.13%-0.32%-3.63%-1.43%
1 Year Performance-8.15%-15.40%3.34%108.46%

MEDIROM Healthcare Technologies Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XWEL
XWELL
1.1658 of 5 stars		$1.78
+1.1%		$7.00
+293.3%		-62.6%$7.44M$30.11M-0.26266
NTRB
Nutriband
0 of 5 stars		$3.47
+1.5%		N/A+1.8%$27.17M$2.08M-5.183
FBRX
Forte Biosciences
2.9736 of 5 stars		$0.73
+1.4%		$2.75
+276.2%		-29.2%$26.61MN/A-0.709Gap Up
APRE
Aprea Therapeutics
3.3666 of 5 stars		$5.10
+0.4%		$15.50
+203.9%		+30.3%$27.69M$580,000.00-1.287
ACST
Acasti Pharma
1.8843 of 5 stars		$2.78
+3.7%		$6.00
+115.8%		+2.5%$26.13MN/A-0.5532
FEMY
Femasys
2.5826 of 5 stars		$1.27
-3.8%		$11.33
+792.4%		+85.2%$28.07M$1.07M-1.3832Gap Up
BIAF
bioAffinity Technologies
0 of 5 stars		$2.45
-3.2%		N/A+4.0%$28.20M$2.53M-2.7214
UBX
Unity Biotechnology
3.6532 of 5 stars		$1.54
+2.0%		$6.00
+289.6%		-31.9%$25.86M$240,000.00-0.5222Upcoming Earnings
BCLI
Brainstorm Cell Therapeutics
0.3722 of 5 stars		$0.38
-29.8%		N/A-85.4%$25.80MN/A-0.9229Analyst Forecast
EVGN
Evogene
1.3931 of 5 stars		$0.69
+6.1%		$3.62
+422.0%		+18.0%$28.56M$5.64M-1.31142Upcoming Earnings

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NYSE:MRM) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners
Tech GIANT’s Plans to Revolutionize Crypto…
Crypto 101 Media
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Dems have chosen Biden replacement?
Paradigm Press
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Gold Set to EXPLODE!
Gold Safe Exchange
How Biden has already won 2024
Porter & Company
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders